Constantine Davides
Stock Analyst at JMP Securities
(1.02)
# 3,626
Out of 4,761 analysts
83
Total ratings
33.77%
Success rate
-27.15%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Market Outperform | $26 | $24.52 | +6.04% | 2 | Feb 14, 2025 | |
| EVH Evolent Health | Reiterates: Market Outperform | $12 | $10.43 | +15.05% | 6 | Feb 14, 2025 | |
| OPRX OptimizeRx | Reiterates: Market Outperform | $8 | $5.78 | +38.41% | 7 | Feb 6, 2025 | |
| HSTM HealthStream | Reiterates: Market Perform | n/a | $32.88 | - | 2 | Feb 6, 2025 | |
| CCRN Cross Country Healthcare | Reiterates: Market Perform | n/a | $18.10 | - | 2 | Feb 6, 2025 | |
| AMN AMN Healthcare Services | Reiterates: Market Outperform | $34 | $27.58 | +23.28% | 8 | Feb 6, 2025 | |
| OPCH Option Care Health | Reiterates: Market Outperform | $31 → $30 | $32.00 | -6.25% | 3 | Jan 10, 2025 | |
| USPH U.S. Physical Therapy | Initiates: Market Outperform | $113 | $84.21 | +34.19% | 1 | Dec 16, 2024 | |
| ADUS Addus HomeCare | Initiates: Market Outperform | $150 | $109.23 | +37.32% | 1 | Dec 16, 2024 | |
| HQY HealthEquity | Maintains: Market Outperform | $105 → $107 | $108.60 | -1.47% | 4 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.52 | - | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $23.20 | - | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $31.77 | - | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $13.17 | - | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.50 | +250.00% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $1.56 | +7,912.82% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $27.97 | -46.37% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $18.08 | +24.45% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $3.57 | +138.10% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.06 | +1,220.75% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.39 | +2,207.69% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $540 | $1.01 | +53,365.35% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $1.30 | +2,976.92% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.55 | +985.97% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $80 | $1.48 | +5,305.41% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $0.40 | +4,963.29% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $1.74 | +4,785.06% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400,000 | $2.50 | +15,999,900.00% | 1 | Mar 28, 2022 |
Privia Health Group
Feb 14, 2025
Maintains: Market Outperform
Price Target: $26
Current: $24.52
Upside: +6.04%
Evolent Health
Feb 14, 2025
Reiterates: Market Outperform
Price Target: $12
Current: $10.43
Upside: +15.05%
OptimizeRx
Feb 6, 2025
Reiterates: Market Outperform
Price Target: $8
Current: $5.78
Upside: +38.41%
HealthStream
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $32.88
Upside: -
Cross Country Healthcare
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $18.10
Upside: -
AMN Healthcare Services
Feb 6, 2025
Reiterates: Market Outperform
Price Target: $34
Current: $27.58
Upside: +23.28%
Option Care Health
Jan 10, 2025
Reiterates: Market Outperform
Price Target: $31 → $30
Current: $32.00
Upside: -6.25%
U.S. Physical Therapy
Dec 16, 2024
Initiates: Market Outperform
Price Target: $113
Current: $84.21
Upside: +34.19%
Addus HomeCare
Dec 16, 2024
Initiates: Market Outperform
Price Target: $150
Current: $109.23
Upside: +37.32%
HealthEquity
Dec 10, 2024
Maintains: Market Outperform
Price Target: $105 → $107
Current: $108.60
Upside: -1.47%
Nov 11, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $3.52
Upside: -
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $23.20
Upside: -
Jul 16, 2024
Initiates: Market Perform
Price Target: n/a
Current: $31.77
Upside: -
Jul 10, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $13.17
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.50
Upside: +250.00%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $1.56
Upside: +7,912.82%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $27.97
Upside: -46.37%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $18.08
Upside: +24.45%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $3.57
Upside: +138.10%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.06
Upside: +1,220.75%
Apr 19, 2023
Reiterates: Buy
Price Target: $9
Current: $0.39
Upside: +2,207.69%
Apr 13, 2023
Reiterates: Buy
Price Target: $540
Current: $1.01
Upside: +53,365.35%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $1.30
Upside: +2,976.92%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.55
Upside: +985.97%
Sep 28, 2022
Maintains: Buy
Price Target: $140 → $80
Current: $1.48
Upside: +5,305.41%
Sep 28, 2022
Maintains: Buy
Price Target: $40 → $20
Current: $0.40
Upside: +4,963.29%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $1.74
Upside: +4,785.06%
Mar 28, 2022
Initiates: Buy
Price Target: $400,000
Current: $2.50
Upside: +15,999,900.00%